Patents by Inventor Yanyun GU

Yanyun GU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210128649
    Abstract: The present invention provides a composition for promoting glucolipid metabolism, and a preparation and an application thereof, and relates to the technical field of probiotics. The composition of the present invention includes probiotics and inulin; the probiotics include Bifidobacterium longum, Bifidobacterium breve, Lactobacillus gasseri, Lactobacillus rhamnosus, Lactobacillus salivarius, Lactobacillus cripatus, Lactobacillus plantarum, Lactobacillus fermentum, and Lactobacillus casei. In the composition of the present invention, the nine strains synergize with each other, which function as a regulator of glucolipid metabolism, improve sensitivity to insulin receptor in the body, and relieve insulin resistance when reconstituted with inulin. The composition has some effects on improving serum total cholesterol and triglyceride, islet ?-cell function, and type 2 diabetes mellitus.
    Type: Application
    Filed: October 31, 2019
    Publication date: May 6, 2021
    Inventors: Guang Ning, Weiqing Wang, Yanyun Gu, Yifei Zhang, Yizhi Xia, Suzhong Jia
  • Publication number: 20180340225
    Abstract: An intestinal microorganism metagenomic feature is a bacteroid intestinal pattern. By using the intestinal metagenomic pattern, it was found that type 2 diabetic patients with different intestinal parasitic bacterial flora had remarkably different responses to treatment with the diabetic hypoglycemic drug acarbose. Therefore, before treatments, the intestinal patterns of the patients can be assessed to select those patients likely to experience optimal curative effects, and to determine whether acarbose is suitable for the treatment of individual patients with type 2 diabetes. In addition, while intestinal patterns are conventionally distinguished by DNA sequencing or PCT amplification of parasitic bacteria in excrements, the intestinal patterns can be well distinguished using a bile acid composition, especially secondary bile acids, under baseline conditions. The intestinal patterns can be identified through markers in blood, and then be used as markers for diagnosis.
    Type: Application
    Filed: December 16, 2015
    Publication date: November 29, 2018
    Applicants: SHANGHAI INSTITUTE FOR ENDOCRINE AND METABOLIC DISEASES, BGI Shenzhen
    Inventors: Guang NING, Dongya ZHANG, Weiqing WANG, Xiaokai WANG, Yanyun GU, Qiang FENG, Ruixin LIU, Xiaoqiang XU, Huahui REN, Huanzi ZHONG